Author: Kim, Sung-Kwon; Cornberg, Markus; Wang, Xiaoting Z.; Chen, Hong D.; Selin, Liisa K.; Welsh, Raymond M.
Title: Private specificities of CD8 T cell responses control patterns of heterologous immunity Document date: 2005_2_21
ID: 55gi6gyx_1
Snippet: Variations in the pathogenesis of viral infections can sometimes be attributed to the infection history of a host, where exposure to unrelated pathogens may unexpectedly contribute either to protective immunity or to enhanced immunopathology (1). This heterologous immunity has now been demonstrated in several murine models of infection, where T cells specific to previously encountered viruses participate in the immune response to viruses subseque.....
Document: Variations in the pathogenesis of viral infections can sometimes be attributed to the infection history of a host, where exposure to unrelated pathogens may unexpectedly contribute either to protective immunity or to enhanced immunopathology (1). This heterologous immunity has now been demonstrated in several murine models of infection, where T cells specific to previously encountered viruses participate in the immune response to viruses subsequently encountered (2) (3) (4) . Recent work showing human T cell cross-reactivity between influenza virus and hepatitis C virus (5) , between influenza virus and Epstein-Barr virus (6) , between human papilloma virus and coronavirus (7) , and between different strains of dengue virus (8) argues that similar issues of heterologous immunity should be examined in human infections.
Search related documents:
Co phrase search for related documents- coronavirus human papilloma virus and Epstein Barr virus: 1, 2
- coronavirus human papilloma virus and Epstein Barr virus influenza virus: 1
- coronavirus human papilloma virus and human papilloma virus: 1, 2, 3
- coronavirus human papilloma virus and influenza virus: 1, 2
- coronavirus human papilloma virus and papilloma virus: 1, 2, 3
- dengue virus and different strain: 1
- dengue virus and Epstein Barr virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- dengue virus and Epstein Barr virus influenza virus: 1, 2
- dengue virus and heterologous immunity: 1, 2, 3
- dengue virus and human infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
- dengue virus and human papilloma virus: 1, 2, 3, 4, 5, 6
- dengue virus and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- dengue virus and infection history: 1, 2, 3
- dengue virus and infection murine model: 1
- dengue virus and influenza virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
- dengue virus and murine model: 1, 2
- dengue virus and papilloma virus: 1, 2, 3, 4, 5, 6
- dengue virus and protective immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- dengue virus and recent work: 1, 2
Co phrase search for related documents, hyperlinks ordered by date